Ivan M. Borrello - 19 Oct 2023 Form 4/A - Amendment Insider Report for Gamida Cell Ltd.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 19 Oct 2023
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 20 Oct 2023, 16:34:11 UTC
Original report date: 10 Feb 2023
Prior SEC filing: 10 Feb 2023
Next SEC filing: 02 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Joshua F. Patterson, Attorney-in-Fact

Key filing fact

Ivan M. Borrello filed Form 4/A - Amendment for Gamida Cell Ltd. on 20 Oct 2023.

Key facts

This page summarizes Ivan M. Borrello's Form 4/A - Amendment filing for Gamida Cell Ltd..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Oct 2023, 16:34.

Change

Previous filing in this sequence was filed on 10 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GMDA transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +28,300
Change %: +708%
Price: $0.000000
Shares after: 32,300
Date: 19 Oct 2023
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GMDA transaction Derivative

Share Option (Right to Buy)

Award

Transaction value: $0
Shares: +56,600
Change %
Price: $0.000000
Shares after: 56,600
Date: 19 Oct 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 56,600
Exercise price: $1.59
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The restricted stock unit ("RSU") award was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the award at the annual general meeting of the shareholders on October 19, 2023.

Footnote F2

Represents an RSU award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date.

Footnote F3

The option grant was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on October 19, 2023.

Footnote F4

This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date.

SEC remarks

This amendment is being filed solely to correct the transaction dates to October 19, 2023 and to correct the expiration date of the option grant to October 18, 2033.